Benjamin Rich is an accomplished cell biologist, currently serving as the Director of Cell Biology at Celcuity. He has accumulated extensive experience in cancer research and treatment during his time as a Scientist at the Dana-Farber Cancer Institute. With a strong academic background, Rich holds a Bachelor of Science in Biology from the College of William and Mary and a Ph.D. in Cellular and Molecular Physiology from the Johns Hopkins University School of Medicine. He has several publications in peer-reviewed scientific journals and has presented his research findings at various conferences worldwide.

Rich has a passion for advancing cancer research and finding new treatments that can benefit patients. His expertise in cell biology and cancer research has equipped him with a comprehensive understanding of cancer pathogenesis and the molecular basis of drug resistance. His current work at Celcuity involves developing new diagnostic tests to help doctors select the most effective therapies for cancer patients. Rich's dedication and commitment to improving cancer treatment make him an invaluable asset to the field of oncology.